Sex	O
-	O
Based	O
Differences	O
in	O
Cardiometabolic	B:C3887460
Biomarkers	O
.	O

Sex	O
-	O
Based	O
Differences	O
in	O
Cardiometabolic	O
Biomarkers	B:C0005516
.	O

Few	O
data	O
are	O
available	O
comparing	O
cardiovascular	B:C0007222
disease	I:C0007222
(	O
cardiovascular	O
disease	I:C0007222
)	O
biomarker	O
profiles	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

Few	O
data	O
are	O
available	O
comparing	O
cardiovascular	O
disease	I:C0007222
(	O
cardiovascular	B:C0007222
disease	I:C0007222
)	O
biomarker	O
profiles	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

Few	O
data	O
are	O
available	O
comparing	O
cardiovascular	O
disease	I:C0007222
(	O
cardiovascular	O
disease	I:C0007222
)	O
biomarker	B:C0005516
profiles	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

Few	O
data	O
are	O
available	O
comparing	O
cardiovascular	O
disease	I:C0007222
(	O
cardiovascular	O
disease	I:C0007222
)	O
biomarker	O
profiles	O
between	O
women	B:C0043210
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

Few	O
data	O
are	O
available	O
comparing	O
cardiovascular	O
disease	I:C0007222
(	O
cardiovascular	O
disease	I:C0007222
)	O
biomarker	O
profiles	O
between	O
women	O
and	O
men	B:C0025266
in	O
the	O
general	O
population	I:C0683971
.	O

Few	O
data	O
are	O
available	O
comparing	O
cardiovascular	O
disease	I:C0007222
(	O
cardiovascular	O
disease	I:C0007222
)	O
biomarker	O
profiles	O
between	O
women	O
and	O
men	O
in	O
the	O
general	B:C0683971
population	I:C0683971
.	O

We	O
analyzed	B:C0936012
sex	O
-	O
based	O
differences	O
in	O
multiple	O
biomarkers	O
reflecting	O
distinct	O
pathophysiological	O
pathways	O
,	O
accounting	O
for	O
differences	O
between	O
women	O
and	O
men	O
in	O
cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
body	O
composition	O
,	O
and	O
cardiac	O
morphology	O
.	O

We	O
analyzed	O
sex	O
-	O
based	O
differences	O
in	O
multiple	O
biomarkers	B:C0005516
reflecting	O
distinct	O
pathophysiological	O
pathways	O
,	O
accounting	O
for	O
differences	O
between	O
women	O
and	O
men	O
in	O
cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
body	O
composition	O
,	O
and	O
cardiac	O
morphology	O
.	O

We	O
analyzed	O
sex	O
-	O
based	O
differences	O
in	O
multiple	O
biomarkers	O
reflecting	O
distinct	O
pathophysiological	O
pathways	O
,	O
accounting	O
for	O
differences	O
between	O
women	B:C0043210
and	O
men	O
in	O
cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
body	O
composition	O
,	O
and	O
cardiac	O
morphology	O
.	O

We	O
analyzed	O
sex	O
-	O
based	O
differences	O
in	O
multiple	O
biomarkers	O
reflecting	O
distinct	O
pathophysiological	O
pathways	O
,	O
accounting	O
for	O
differences	O
between	O
women	O
and	O
men	B:C0025266
in	O
cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
body	O
composition	O
,	O
and	O
cardiac	O
morphology	O
.	O

We	O
analyzed	O
sex	O
-	O
based	O
differences	O
in	O
multiple	O
biomarkers	O
reflecting	O
distinct	O
pathophysiological	O
pathways	O
,	O
accounting	O
for	O
differences	O
between	O
women	O
and	O
men	O
in	O
cardiovascular	B:C0007222
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
body	O
composition	O
,	O
and	O
cardiac	O
morphology	O
.	O

We	O
analyzed	O
sex	O
-	O
based	O
differences	O
in	O
multiple	O
biomarkers	O
reflecting	O
distinct	O
pathophysiological	O
pathways	O
,	O
accounting	O
for	O
differences	O
between	O
women	O
and	O
men	O
in	O
cardiovascular	O
disease	I:C0007222
risk	B:C0035648
factors	I:C0035648
,	O
body	O
composition	O
,	O
and	O
cardiac	O
morphology	O
.	O

We	O
analyzed	O
sex	O
-	O
based	O
differences	O
in	O
multiple	O
biomarkers	O
reflecting	O
distinct	O
pathophysiological	O
pathways	O
,	O
accounting	O
for	O
differences	O
between	O
women	O
and	O
men	O
in	O
cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
body	O
composition	O
,	O
and	O
cardiac	B:C0018787
morphology	O
.	O

A	O
cross-sectional	B:C0010362
analysis	I:C0010362
was	O
performed	O
using	O
data	O
from	O
the	O
Dallas	O
Heart	I:C0681876
Study	I:C0681876
,	O
a	O
multiethnic	O
population	I:C0681876
-	I:C0681876
based	I:C0681876
study	I:C0681876
.	O

A	O
cross-sectional	O
analysis	I:C0010362
was	O
performed	O
using	O
data	O
from	O
the	O
Dallas	B:C0681876
Heart	I:C0681876
Study	I:C0681876
,	O
a	O
multiethnic	O
population	I:C0681876
-	I:C0681876
based	I:C0681876
study	I:C0681876
.	O

A	O
cross-sectional	O
analysis	I:C0010362
was	O
performed	O
using	O
data	O
from	O
the	O
Dallas	O
Heart	I:C0681876
Study	I:C0681876
,	O
a	O
multiethnic	B:C0681876
population	I:C0681876
-	I:C0681876
based	I:C0681876
study	I:C0681876
.	O

Associations	O
between	O
sex	O
and	O
30	O
distinct	O
biomarkers	B:C0005516
representative	O
of	O
6	O
pathophysiological	O
categories	O
were	O
evaluated	O
using	O
multivariable	O
linear	O
regression	O
adjusting	O
for	O
age	O
,	O
race	O
,	O
traditional	O
cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
kidney	O
function	I:C0232804
,	O
insulin	O
resistance	I:C0021655
,	O
MRI	O
and	O
dual	O
-	I:C1510486
energy	I:C1510486
x-ray	I:C1510486
absorptiometry	I:C1510486
measures	O
of	O
body	O
composition	O
and	O
fat	O
distribution	I:C0424621
,	O
and	O
left	O
ventricular	I:C0455825
mass	I:C0455825
.	O

Associations	O
between	O
sex	O
and	O
30	O
distinct	O
biomarkers	O
representative	O
of	O
6	O
pathophysiological	O
categories	B:C0683312
were	O
evaluated	O
using	O
multivariable	O
linear	O
regression	O
adjusting	O
for	O
age	O
,	O
race	O
,	O
traditional	O
cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
kidney	O
function	I:C0232804
,	O
insulin	O
resistance	I:C0021655
,	O
MRI	O
and	O
dual	O
-	I:C1510486
energy	I:C1510486
x-ray	I:C1510486
absorptiometry	I:C1510486
measures	O
of	O
body	O
composition	O
and	O
fat	O
distribution	I:C0424621
,	O
and	O
left	O
ventricular	I:C0455825
mass	I:C0455825
.	O

Associations	O
between	O
sex	O
and	O
30	O
distinct	O
biomarkers	O
representative	O
of	O
6	O
pathophysiological	O
categories	O
were	O
evaluated	B:C0220825
using	O
multivariable	O
linear	O
regression	O
adjusting	O
for	O
age	O
,	O
race	O
,	O
traditional	O
cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
kidney	O
function	I:C0232804
,	O
insulin	O
resistance	I:C0021655
,	O
MRI	O
and	O
dual	O
-	I:C1510486
energy	I:C1510486
x-ray	I:C1510486
absorptiometry	I:C1510486
measures	O
of	O
body	O
composition	O
and	O
fat	O
distribution	I:C0424621
,	O
and	O
left	O
ventricular	I:C0455825
mass	I:C0455825
.	O

Associations	O
between	O
sex	O
and	O
30	O
distinct	O
biomarkers	O
representative	O
of	O
6	O
pathophysiological	O
categories	O
were	O
evaluated	O
using	O
multivariable	O
linear	O
regression	O
adjusting	O
for	O
age	O
,	O
race	B:C0034510
,	O
traditional	O
cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
kidney	O
function	I:C0232804
,	O
insulin	O
resistance	I:C0021655
,	O
MRI	O
and	O
dual	O
-	I:C1510486
energy	I:C1510486
x-ray	I:C1510486
absorptiometry	I:C1510486
measures	O
of	O
body	O
composition	O
and	O
fat	O
distribution	I:C0424621
,	O
and	O
left	O
ventricular	I:C0455825
mass	I:C0455825
.	O

Associations	O
between	O
sex	O
and	O
30	O
distinct	O
biomarkers	O
representative	O
of	O
6	O
pathophysiological	O
categories	O
were	O
evaluated	O
using	O
multivariable	O
linear	O
regression	O
adjusting	O
for	O
age	O
,	O
race	O
,	O
traditional	O
cardiovascular	B:C0007222
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
kidney	O
function	I:C0232804
,	O
insulin	O
resistance	I:C0021655
,	O
MRI	O
and	O
dual	O
-	I:C1510486
energy	I:C1510486
x-ray	I:C1510486
absorptiometry	I:C1510486
measures	O
of	O
body	O
composition	O
and	O
fat	O
distribution	I:C0424621
,	O
and	O
left	O
ventricular	I:C0455825
mass	I:C0455825
.	O

Associations	O
between	O
sex	O
and	O
30	O
distinct	O
biomarkers	O
representative	O
of	O
6	O
pathophysiological	O
categories	O
were	O
evaluated	O
using	O
multivariable	O
linear	O
regression	O
adjusting	O
for	O
age	O
,	O
race	O
,	O
traditional	O
cardiovascular	O
disease	I:C0007222
risk	B:C0035648
factors	I:C0035648
,	O
kidney	O
function	I:C0232804
,	O
insulin	O
resistance	I:C0021655
,	O
MRI	O
and	O
dual	O
-	I:C1510486
energy	I:C1510486
x-ray	I:C1510486
absorptiometry	I:C1510486
measures	O
of	O
body	O
composition	O
and	O
fat	O
distribution	I:C0424621
,	O
and	O
left	O
ventricular	I:C0455825
mass	I:C0455825
.	O

Associations	O
between	O
sex	O
and	O
30	O
distinct	O
biomarkers	O
representative	O
of	O
6	O
pathophysiological	O
categories	O
were	O
evaluated	O
using	O
multivariable	O
linear	O
regression	O
adjusting	O
for	O
age	O
,	O
race	O
,	O
traditional	O
cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
kidney	B:C0232804
function	I:C0232804
,	O
insulin	O
resistance	I:C0021655
,	O
MRI	O
and	O
dual	O
-	I:C1510486
energy	I:C1510486
x-ray	I:C1510486
absorptiometry	I:C1510486
measures	O
of	O
body	O
composition	O
and	O
fat	O
distribution	I:C0424621
,	O
and	O
left	O
ventricular	I:C0455825
mass	I:C0455825
.	O

Associations	O
between	O
sex	O
and	O
30	O
distinct	O
biomarkers	O
representative	O
of	O
6	O
pathophysiological	O
categories	O
were	O
evaluated	O
using	O
multivariable	O
linear	O
regression	O
adjusting	O
for	O
age	O
,	O
race	O
,	O
traditional	O
cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
kidney	O
function	I:C0232804
,	O
insulin	B:C0021655
resistance	I:C0021655
,	O
MRI	O
and	O
dual	O
-	I:C1510486
energy	I:C1510486
x-ray	I:C1510486
absorptiometry	I:C1510486
measures	O
of	O
body	O
composition	O
and	O
fat	O
distribution	I:C0424621
,	O
and	O
left	O
ventricular	I:C0455825
mass	I:C0455825
.	O

Associations	O
between	O
sex	O
and	O
30	O
distinct	O
biomarkers	O
representative	O
of	O
6	O
pathophysiological	O
categories	O
were	O
evaluated	O
using	O
multivariable	O
linear	O
regression	O
adjusting	O
for	O
age	O
,	O
race	O
,	O
traditional	O
cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
kidney	O
function	I:C0232804
,	O
insulin	O
resistance	I:C0021655
,	O
MRI	B:C0024485
and	O
dual	O
-	I:C1510486
energy	I:C1510486
x-ray	I:C1510486
absorptiometry	I:C1510486
measures	O
of	O
body	O
composition	O
and	O
fat	O
distribution	I:C0424621
,	O
and	O
left	O
ventricular	I:C0455825
mass	I:C0455825
.	O

Associations	O
between	O
sex	O
and	O
30	O
distinct	O
biomarkers	O
representative	O
of	O
6	O
pathophysiological	O
categories	O
were	O
evaluated	O
using	O
multivariable	O
linear	O
regression	O
adjusting	O
for	O
age	O
,	O
race	O
,	O
traditional	O
cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
kidney	O
function	I:C0232804
,	O
insulin	O
resistance	I:C0021655
,	O
MRI	O
and	O
dual	B:C1510486
-	I:C1510486
energy	I:C1510486
x-ray	I:C1510486
absorptiometry	I:C1510486
measures	O
of	O
body	O
composition	O
and	O
fat	O
distribution	I:C0424621
,	O
and	O
left	O
ventricular	I:C0455825
mass	I:C0455825
.	O

Associations	O
between	O
sex	O
and	O
30	O
distinct	O
biomarkers	O
representative	O
of	O
6	O
pathophysiological	O
categories	O
were	O
evaluated	O
using	O
multivariable	O
linear	O
regression	O
adjusting	O
for	O
age	O
,	O
race	O
,	O
traditional	O
cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
kidney	O
function	I:C0232804
,	O
insulin	O
resistance	I:C0021655
,	O
MRI	O
and	O
dual	O
-	I:C1510486
energy	I:C1510486
x-ray	I:C1510486
absorptiometry	I:C1510486
measures	O
of	O
body	O
composition	O
and	O
fat	B:C0424621
distribution	I:C0424621
,	O
and	O
left	O
ventricular	I:C0455825
mass	I:C0455825
.	O

Associations	O
between	O
sex	O
and	O
30	O
distinct	O
biomarkers	O
representative	O
of	O
6	O
pathophysiological	O
categories	O
were	O
evaluated	O
using	O
multivariable	O
linear	O
regression	O
adjusting	O
for	O
age	O
,	O
race	O
,	O
traditional	O
cardiovascular	O
disease	I:C0007222
risk	O
factors	I:C0035648
,	O
kidney	O
function	I:C0232804
,	O
insulin	O
resistance	I:C0021655
,	O
MRI	O
and	O
dual	O
-	I:C1510486
energy	I:C1510486
x-ray	I:C1510486
absorptiometry	I:C1510486
measures	O
of	O
body	O
composition	O
and	O
fat	O
distribution	I:C0424621
,	O
and	O
left	B:C0455825
ventricular	I:C0455825
mass	I:C0455825
.	O

After	O
excluding	O
participants	B:C0679646
with	O
cardiovascular	O
disease	I:C0007222
,	O
the	O
study	O
population	I:C2348561
included	O
3439	O
individuals	O
,	O
mean	O
age	O
43	O
years	O
,	O
56	O
%	O
women	O
,	O
and	O
52	O
%	O
black	O
.	O

After	O
excluding	O
participants	O
with	O
cardiovascular	B:C0007222
disease	I:C0007222
,	O
the	O
study	O
population	I:C2348561
included	O
3439	O
individuals	O
,	O
mean	O
age	O
43	O
years	O
,	O
56	O
%	O
women	O
,	O
and	O
52	O
%	O
black	O
.	O

After	O
excluding	O
participants	O
with	O
cardiovascular	O
disease	I:C0007222
,	O
the	O
study	B:C2348561
population	I:C2348561
included	O
3439	O
individuals	O
,	O
mean	O
age	O
43	O
years	O
,	O
56	O
%	O
women	O
,	O
and	O
52	O
%	O
black	O
.	O

After	O
excluding	O
participants	O
with	O
cardiovascular	O
disease	I:C0007222
,	O
the	O
study	O
population	I:C2348561
included	O
3439	O
individuals	B:C0027361
,	O
mean	O
age	O
43	O
years	O
,	O
56	O
%	O
women	O
,	O
and	O
52	O
%	O
black	O
.	O

After	O
excluding	O
participants	O
with	O
cardiovascular	O
disease	I:C0007222
,	O
the	O
study	O
population	I:C2348561
included	O
3439	O
individuals	O
,	O
mean	O
age	O
43	O
years	O
,	O
56	O
%	O
women	B:C0043210
,	O
and	O
52	O
%	O
black	O
.	O

After	O
excluding	O
participants	O
with	O
cardiovascular	O
disease	I:C0007222
,	O
the	O
study	O
population	I:C2348561
included	O
3439	O
individuals	O
,	O
mean	O
age	O
43	O
years	O
,	O
56	O
%	O
women	O
,	O
and	O
52	O
%	O
black	B:C0005680
.	O

Significant	O
sex	O
-	O
based	O
differences	O
were	O
seen	O
in	O
multiple	O
categories	B:C0683312
of	O
biomarkers	O
,	O
including	O
lipids	O
,	O
adipokines	O
,	O
and	O
biomarkers	O
of	O
inflammation	O
,	O
endothelial	O
dysfunction	I:C0856169
,	O
myocyte	O
injury	O
and	O
stress	O
,	O
and	O
kidney	O
function	I:C0232804
.	O

Significant	O
sex	O
-	O
based	O
differences	O
were	O
seen	O
in	O
multiple	O
categories	O
of	O
biomarkers	B:C0005516
,	O
including	O
lipids	O
,	O
adipokines	O
,	O
and	O
biomarkers	O
of	O
inflammation	O
,	O
endothelial	O
dysfunction	I:C0856169
,	O
myocyte	O
injury	O
and	O
stress	O
,	O
and	O
kidney	O
function	I:C0232804
.	O

Significant	O
sex	O
-	O
based	O
differences	O
were	O
seen	O
in	O
multiple	O
categories	O
of	O
biomarkers	O
,	O
including	O
lipids	B:C0023779
,	O
adipokines	O
,	O
and	O
biomarkers	O
of	O
inflammation	O
,	O
endothelial	O
dysfunction	I:C0856169
,	O
myocyte	O
injury	O
and	O
stress	O
,	O
and	O
kidney	O
function	I:C0232804
.	O

Significant	O
sex	O
-	O
based	O
differences	O
were	O
seen	O
in	O
multiple	O
categories	O
of	O
biomarkers	O
,	O
including	O
lipids	O
,	O
adipokines	B:C1955907
,	O
and	O
biomarkers	O
of	O
inflammation	O
,	O
endothelial	O
dysfunction	I:C0856169
,	O
myocyte	O
injury	O
and	O
stress	O
,	O
and	O
kidney	O
function	I:C0232804
.	O

Significant	O
sex	O
-	O
based	O
differences	O
were	O
seen	O
in	O
multiple	O
categories	O
of	O
biomarkers	O
,	O
including	O
lipids	O
,	O
adipokines	O
,	O
and	O
biomarkers	B:C0005516
of	O
inflammation	O
,	O
endothelial	O
dysfunction	I:C0856169
,	O
myocyte	O
injury	O
and	O
stress	O
,	O
and	O
kidney	O
function	I:C0232804
.	O

Significant	O
sex	O
-	O
based	O
differences	O
were	O
seen	O
in	O
multiple	O
categories	O
of	O
biomarkers	O
,	O
including	O
lipids	O
,	O
adipokines	O
,	O
and	O
biomarkers	O
of	O
inflammation	B:C0021368
,	O
endothelial	O
dysfunction	I:C0856169
,	O
myocyte	O
injury	O
and	O
stress	O
,	O
and	O
kidney	O
function	I:C0232804
.	O

Significant	O
sex	O
-	O
based	O
differences	O
were	O
seen	O
in	O
multiple	O
categories	O
of	O
biomarkers	O
,	O
including	O
lipids	O
,	O
adipokines	O
,	O
and	O
biomarkers	O
of	O
inflammation	O
,	O
endothelial	B:C0856169
dysfunction	I:C0856169
,	O
myocyte	O
injury	O
and	O
stress	O
,	O
and	O
kidney	O
function	I:C0232804
.	O

Significant	O
sex	O
-	O
based	O
differences	O
were	O
seen	O
in	O
multiple	O
categories	O
of	O
biomarkers	O
,	O
including	O
lipids	O
,	O
adipokines	O
,	O
and	O
biomarkers	O
of	O
inflammation	O
,	O
endothelial	O
dysfunction	I:C0856169
,	O
myocyte	B:C0596981
injury	O
and	O
stress	O
,	O
and	O
kidney	O
function	I:C0232804
.	O

Significant	O
sex	O
-	O
based	O
differences	O
were	O
seen	O
in	O
multiple	O
categories	O
of	O
biomarkers	O
,	O
including	O
lipids	O
,	O
adipokines	O
,	O
and	O
biomarkers	O
of	O
inflammation	O
,	O
endothelial	O
dysfunction	I:C0856169
,	O
myocyte	O
injury	O
and	O
stress	B:C1516360
,	O
and	O
kidney	O
function	I:C0232804
.	O

Significant	O
sex	O
-	O
based	O
differences	O
were	O
seen	O
in	O
multiple	O
categories	O
of	O
biomarkers	O
,	O
including	O
lipids	O
,	O
adipokines	O
,	O
and	O
biomarkers	O
of	O
inflammation	O
,	O
endothelial	O
dysfunction	I:C0856169
,	O
myocyte	O
injury	O
and	O
stress	O
,	O
and	O
kidney	B:C0232804
function	I:C0232804
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	B:C0043210
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	B:C0023822
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	B:C0023821
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	B:C0299583
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	B:C0060323
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	B:C0019877
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	B:C0023824
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	B:C0389071
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	B:C0023820
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	B:C0031667
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	B:C0243102
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	B:C0128897
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	B:C3253526
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	B:C0332516
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	B:C1453836
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	B:C0332514
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	B:C1453836
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	B:C0077404
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	B:C0071744
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	B:C0005516
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	B:C0043210
and	O
men	O
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	B:C0025266
in	O
the	O
general	O
population	I:C0683971
.	O

In	O
fully	O
adjusted	O
models	O
,	O
women	O
had	O
higher	O
levels	O
of	O
high	O
-	I:C0023822
density	I:C0023822
lipoprotein	I:C0023822
cholesterol	I:C0023822
and	O
high	O
-	I:C0023821
density	I:C0023821
lipoprotein	I:C0023821
particle	I:C0023821
concentration	O
,	O
leptin	O
,	O
d-	O
dimer	I:C0060323
,	O
homoarginine	O
,	O
and	O
N	O
-	I:C0754710
terminal	I:C0754710
pro	I:C0754710
B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
and	O
lower	O
levels	O
of	O
low	O
-	I:C0023824
density	I:C0023824
lipoprotein	I:C0023824
cholesterol	I:C0023824
,	O
adiponectin	O
,	O
lipoprotein	O
-	O
associated	O
phospholipase	O
A2	I:C0031667
mass	O
and	O
activity	O
,	O
monocyte	O
chemoattractant	I:C0128897
protein	I:C0128897
-	I:C0128897
1	I:C0128897
,	O
soluble	O
endothelial	O
cell	I:C3253526
adhesion	I:C3253526
molecule	I:C3253526
,	O
symmetrical	O
dimethylarginine	O
,	O
asymmetrical	O
dimethylarginine	O
,	O
high	O
-	O
sensitivity	O
troponin	O
T	I:C0077404
,	O
and	O
cystatin	O
C.	I:C0071744
Biomarker	O
profiles	O
differ	O
significantly	O
between	O
women	O
and	O
men	O
in	O
the	O
general	B:C0683971
population	I:C0683971
.	O

Sex	O
differences	O
were	O
most	O
apparent	O
for	O
biomarkers	B:C0005516
of	O
adiposity	O
,	O
endothelial	O
dysfunction	I:C0856169
,	O
inflammatory	O
cell	I:C0243095
recruitment	I:C0243095
,	O
and	O
cardiac	O
stress	I:C2317276
and	O
injury	O
.	O

Sex	O
differences	O
were	O
most	O
apparent	O
for	O
biomarkers	O
of	O
adiposity	O
,	O
endothelial	B:C0856169
dysfunction	I:C0856169
,	O
inflammatory	O
cell	I:C0243095
recruitment	I:C0243095
,	O
and	O
cardiac	O
stress	I:C2317276
and	O
injury	O
.	O

Sex	O
differences	O
were	O
most	O
apparent	O
for	O
biomarkers	O
of	O
adiposity	O
,	O
endothelial	O
dysfunction	I:C0856169
,	O
inflammatory	B:C0243095
cell	I:C0243095
recruitment	I:C0243095
,	O
and	O
cardiac	O
stress	I:C2317276
and	O
injury	O
.	O

Sex	O
differences	O
were	O
most	O
apparent	O
for	O
biomarkers	O
of	O
adiposity	O
,	O
endothelial	O
dysfunction	I:C0856169
,	O
inflammatory	O
cell	I:C0243095
recruitment	I:C0243095
,	O
and	O
cardiac	B:C2317276
stress	I:C2317276
and	O
injury	O
.	O

Sex	O
differences	O
were	O
most	O
apparent	O
for	O
biomarkers	O
of	O
adiposity	O
,	O
endothelial	O
dysfunction	I:C0856169
,	O
inflammatory	O
cell	I:C0243095
recruitment	I:C0243095
,	O
and	O
cardiac	O
stress	I:C2317276
and	O
injury	B:C0018805
.	O

Future	O
studies	O
are	O
needed	O
to	O
characterize	O
whether	O
pathophysiological	O
processes	O
delineated	O
by	O
these	O
biomarkers	B:C0005516
contribute	O
to	O
sex	O
-	O
based	O
differences	O
in	O
the	O
development	O
and	O
complications	O
of	O
cardiovascular	O
disease	I:C0007222
.	O

Future	O
studies	O
are	O
needed	O
to	O
characterize	O
whether	O
pathophysiological	O
processes	O
delineated	O
by	O
these	O
biomarkers	O
contribute	O
to	O
sex	O
-	O
based	O
differences	O
in	O
the	O
development	O
and	O
complications	B:C0009566
of	O
cardiovascular	O
disease	I:C0007222
.	O

Future	O
studies	O
are	O
needed	O
to	O
characterize	O
whether	O
pathophysiological	O
processes	O
delineated	O
by	O
these	O
biomarkers	O
contribute	O
to	O
sex	O
-	O
based	O
differences	O
in	O
the	O
development	O
and	O
complications	O
of	O
cardiovascular	B:C0007222
disease	I:C0007222
.	O

